Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell Disease
Phase of Trial: Phase I
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Plerixafor (Primary)
- Indications Sickle cell anaemia
- Focus Adverse reactions; Therapeutic Use
- 23 Jan 2018 Status changed from recruiting to completed.
- 12 Jan 2017 Status changed from not yet recruiting to recruiting.
- 15 Dec 2016 New trial record